These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30566785)

  • 1. Cytapheresis.
    Yokoyama Y; Kamikozuru K; Nakamura S
    Nihon Rinsho; 2017 Mar; 75(3):419-425. PubMed ID: 30566785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy.
    Iizuka M; Etou T; Sagara S
    World J Gastroenterol; 2022 Sep; 28(34):4959-4972. PubMed ID: 36160647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
    Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
    World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis.
    Nomura O; Osada T; Shibuya T; Ishikawa D; Haga K; Kodani T; Sakamoto N; Ogihara T; Yamaji K; Watanabe S
    J Clin Apher; 2018 Feb; 33(1):21-28. PubMed ID: 28581039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytapheresis (CAP) with leukocyte removal filter/bead column as one therapeutic option for inflammatory bowel disease.
    Sawada K
    Transfus Apher Sci; 2017 Oct; 56(5):689-697. PubMed ID: 28986009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis.
    Iizuka M; Etou T; Kumagai M; Matsuoka A; Numata Y; Sagara S
    Intern Med; 2017 Oct; 56(20):2705-2710. PubMed ID: 28924114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte and monocyte adsorptive apheresis (GMA) in patients with inflammatory bowel disease: A useful therapeutic tool not just in ulcerative colitis but also in Crohn's disease.
    Fernández-Pérez FJ; Fernández-Moreno N; Soria-López E; Rodriguez-González FJ; Fernández-Galeote FJ; Lifante-Oliva A; Ruíz-Hernández C; Escalante-Quijaite E; Rivas-Ruiz F
    Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38710467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
    Nakano R; Iwakiri R; Ikeda Y; Kishi T; Tsuruoka N; Shimoda R; Sakata Y; Yamaguchi K; Fujimoto K
    J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis.
    Iizuka M; Etou T; Shimodaira Y; Hatakeyama T; Sagara S
    World J Gastroenterol; 2021 Mar; 27(12):1194-1212. PubMed ID: 33828394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.
    Ruuska T; Wewer V; Lindgren F; Malmborg P; Lindquist M; Marthinsen L; Browaldh L; Casswall T; Kalliomäki M; Grönlund J
    Inflamm Bowel Dis; 2009 Jul; 15(7):1049-54. PubMed ID: 19137602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes.
    Saniabadi AR; Tanaka T; Yamamoto T; Kruis W; Sacco R
    J Clin Apher; 2019 Feb; 34(1):51-60. PubMed ID: 30407662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorptive cytapheresis in ulcerative colitis: A non-pharmacological therapeutic approach revisited.
    Vernia F; Viscido A; Latella G
    J Clin Apher; 2023 Dec; 38(6):746-754. PubMed ID: 37787399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease.
    Yasmin F; Najeeb H; Naeem U; Moeed A; Koritala T; Surani S
    World J Clin Cases; 2022 Jul; 10(21):7195-7208. PubMed ID: 36158031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
    Yokoyama Y; Watanabe K; Ito H; Nishishita M; Sawada K; Okuyama Y; Okazaki K; Fujii H; Nakase H; Masuda T; Fukunaga K; Andoh A; Nakamura S
    Cytotherapy; 2015 May; 17(5):680-8. PubMed ID: 25804800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future perspectives of leukocytapheresis for inflammatory bowel disease.
    Fukunaga K; Matsumoto T
    J Gastroenterol Hepatol; 2012 Jun; 27(6):997-1003. PubMed ID: 22414250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.
    Sáez-González E; Moret I; Alvarez-Sotomayor D; Díaz-Jaime FC; Cerrillo E; Iborra M; Nos P; Beltrán B
    Dig Dis Sci; 2017 Jun; 62(6):1417-1425. PubMed ID: 28432476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questionnaire based assessment of patients' acceptability of leukocytapheresis for the treatment of inflammatory bowel disease.
    Nagase K; Fukuanga K; Yokoyama Y; Kamikozuru K; Miwa H; Nakamura S
    Ther Apher Dial; 2013 Oct; 17(5):490-7. PubMed ID: 24107277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the clinical response to cytapheresis in steroid-refractory or -dependent ulcerative colitis using contrast-enhanced ultrasonography.
    Yamaguchi T; Yoshida S; Tanaka S; Takemura Y; Oka S; Yoshihara M; Yamada H; Chayama K
    Scand J Gastroenterol; 2009; 44(7):831-7. PubMed ID: 19811342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.